GVK BIOSCIENCES
GVK Biosciences (GVK BIO) is one of Asia’s leading Discovery Research and Development organizations. GVK BIO provides a broad spectrum of services, across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO capabilities include Integrated Programs, Discovery Services, Clinical Development, Contract Manufacturing, Formulations and Informatics. GVK BIO has over a decade of rich experience in providing breakthrough drug discovery and development services. Their team ... of scientists, backed by well-laid processes and cutting edge technologies, enable customers to achieve unmatched results. GVK BIO’s 2400 employees serve a diverse and global customer base of more than 300 satisfied customers. They have consistently exceeded their customers’ expectations in terms of quality, speed and affordability. Precisely why, their clientele who are among the global top 10 in the fields of Pharmaceutical, Agrochemical, Electronics, Biotechnology and Academics entrust us with their research challenges.
GVK BIOSCIENCES
Industry:
Manufacturing Search Engine
Founded:
2001-01-01
Address:
Hyderabad, Andhra Pradesh, India
Country:
India
Website Url:
http://www.gvkbio.com
Total Employee:
1001+
Status:
Active
Contact:
7039404088
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling Japanese Yen AWS Global Accelerator
Similar Organizations
BioIntervene
BioIntervene is engages in drug discovery and development.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
HUYA Bioscience
HUYA Bioscience enables and accelerates the global development of novel biopharmaceutical product opportunities.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-15 | Intox | Intox acquired by GVK Biosciences | N/A |
| 2014-11-06 | Vanta Bioscience | Vanta Bioscience acquired by GVK Biosciences | N/A |
| 2014-01-29 | Aragen Bioscience | Aragen Bioscience acquired by GVK Biosciences | N/A |
Investors List
Goldman Sachs Asset Management
Goldman Sachs Asset Management investment in Secondary Market - GVK Biosciences
Chrys Capital
Chrys Capital investment in Secondary Market - GVK Biosciences
Sequoia Capital
Sequoia Capital investment in Venture Round - GVK Biosciences
Official Site Inspections
http://www.gvkbio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
